NCT03230383
- Conditions
- Healthy Subjects
- Locations
-
- Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States
- Pfizer Clinical Research Unit Brussels, Belgium
Clinical trial condition
Healthy Subjects
Explore clinical trials studying Healthy Subjects. Study availability and eligibility vary by location and protocol.
831 public trials
38 recruiting studies
Healthy Subjects trial results
NCT02890147
- Conditions
- Healthy Subjects
- Locations
-
- Medical University of Vienna Vienna, Austria
- UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN) Leuven, Belgium
- CHRU de Brest Brest, France
- Deutsches Rheuma-Forschungszentrum Berlin (DRFZ) Berlin, Germany
NCT03517033
- Conditions
- Healthy Subjects
- Locations
-
Not specified
NCT03517020
- Conditions
- Healthy Subjects
- Locations
-
Not specified
Completed
Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules
NCT03443960
- Conditions
- Healthy Subjects
- Locations
-
- Quebec City Québec, Quebec, Canada
Completed
Study of COR388 HCl in Healthy Subjects
NCT03331900
- Conditions
- Healthy Subjects
- Locations
-
- Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States
Completed
First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects
NCT03309241
- Conditions
- Healthy Subjects
- Locations
-
- New Haven Clinical Research Unit New Haven, Connecticut, United States
NCT00401232
- Conditions
- Healthy Subjects
- Locations
-
- SNBL Clinical Pharmacology Center Baltimore, Maryland, United States
- Frontage Clinical Services Inc Hackensack, New Jersey, United States
NCT03463343
- Conditions
- Healthy Subjects
- Locations
-
Not specified
NCT02073812
- Conditions
- Healthy Subjects
- Locations
-
- Pulmonary Associates Phoenix, Arizona, United States